Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting
Sponsor: Tanta University
Summary
The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.
Official title: Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting: A Randomized Double-Blind Trial
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2022-12-15
Completion Date
2026-05-15
Last Updated
2025-06-25
Healthy Volunteers
No
Interventions
Pregabalin
Patients will receive pregabalin capsules (75 mg) every 12 h for 24 hours by nasogastric tube.
Dexmedetomidine
Patients will receive a bolus dose of 0.4 μg/kg dexmedetomidine (over a period of 10 to 20 min)
Locations (1)
Islam Morsy
Tanta, El-Gharbia Governorate, Egypt